Sign in to view Charles’ full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Charles’ full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Greater Philadelphia
Sign in to view Charles’ full profile
Charles can introduce you to 10+ people at JM Search
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
4K followers
500+ connections
Sign in to view Charles’ full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Charles
Charles can introduce you to 10+ people at JM Search
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Charles
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Charles’ full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
About
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Articles by Charles
-
Future-Ready Healthcare Technology Innovation and Leadership
Future-Ready Healthcare Technology Innovation and Leadership
A Conversation with JM Search As we enter the home stretch of 2020, most would agree it has been an epic year due to…
55
1 Comment -
Talent Recruitment in the post COVID World and BeyondOct 30, 2020
Talent Recruitment in the post COVID World and Beyond
Reflections from the 2020 PEI Operating Partners Forum: It’s all about getting back to the basics. PEI’s Operating…
49
2 Comments
Activity
4K followers
-
Charles Egoville reposted thisCharles Egoville reposted thisOne firm, focused on you.® At JM Search, we're dedicated to identifying exceptional leaders who drive business success. Our 45 year track record spans across industries and functions, bringing clients decades of firsthand executive recruiting experience to ensure the best possible outcomes for our clients and their business. Whether you're looking to fill crucial executive positions or expand your team of next generation leaders, JM Search is your trusted partner. We understand what you’re looking for, what you seek to accomplish, and how hiring the right leaders impacts every stakeholder in your business. We get it because we’ve done it. We have spent years identifying, attracting, and retaining high-performing company builders within our own firm and understand how to scale without sacrificing culture. Ready to elevate your leadership team? Contact us today to get started. https://lnkd.in/gyziA3F8
-
Charles Egoville shared thisIn today’s market, product strength alone is rarely enough to move a deal forward. GTM teams need to show how value translates into measurable business outcomes that buyers can evaluate, defend, and prioritize internally. Scott Wielar explores what stronger ROI communication requires in his latest article: https://lnkd.in/eMix9BZM
-
Charles Egoville shared thisGreat article in today’s WSJ. Nursing is the growth engine of the middle class and AI proof. Interesting stats.Nursing Is the Surefire New Path to American ProsperityNursing Is the Surefire New Path to American Prosperity
-
Charles Egoville reposted thisCharles Egoville reposted thisSometimes I have to pinch myself that this is what I get to do for a living. This week, Thanh Nguyen and I hosted an Executive Women in Leadership Dinner at Nobu Restaurants in Newport Beach, and I was genuinely blown away by the caliber of women in the room. Hearing the stories behind their careers, leadership journeys, and accomplishments was incredibly inspiring. I’m already looking forward to the next one, more to come.
-
Charles Egoville shared thisWe talk about CEO comp with boards constantly – and now we're building a study to give the full community a data-driven benchmark. If you're a current or former CEO across any ownership type, we’d love your input. Takes about 5 minutes here: https://bit.ly/3PZYRLn
-
Charles Egoville shared thisGood advice when people ask the question, “where do I start?”.Charles Egoville shared thisOne question I've gotten about Outlive (& longevity in general) is, where do we even begin? It can feel overwhelming, and there's this idea out there that every single aspect of your life must be "optimized," immediately. I have a slightly different, somewhat wordy take...
-
Charles Egoville shared thisFor many companies, the expectations of the General Counsel role have changed significantly. Boards and CEOs still want strong legal judgment, but they also want someone who can support growth, improve decision-making, and operate as a true strategic partner. In a new article, Dan Figueroa and former senior executive and Chief Legal Officer Michael Yecies explore that shift: https://lnkd.in/eyFx62-x
-
Charles Egoville shared thisRoger Federer made it look effortless.. Great episode that pulls back the curtain on the routine, self discipline, toil, and self doubt behind the scenes of one of the greatest tennis players of all time. He was a master at improving and evolving, never staying stagnant. I love what I learned about resilience and surrounding yourself with great people and mentors.
-
Charles Egoville shared thisIn executive hiring, experience and functional expertise are table stakes. But one trait often predicts how impactful a leader will be: intellectual curiosity. My colleague, Pam Zients, explores why curiosity drives adaptability, learning, and stronger leadership outcomes. Worth a read: https://lnkd.in/eJH8NpRG
-
Charles Egoville liked thisCharles Egoville liked thisThank you to all who responded to my sequence of CEO posts. Many of you have DM me for more input around effective Govtech CEO communication. My Top 10 for your review and comment. 1. Lead with Mission + Impact: GovTech employees are uniquely motivated by purpose. Best CEOs always connect: “What we do” citizens, agencies, real-world impact 2. Be Simple, Repeatable, and Consistent: The best CEOs don’t change the message every week. They consistently reinforce: - 3–5 company priorities - What success looks like this quarter - Where the company is winning / behind 3. Balance Transparency with Direction: GovTech teams deal with uncertainty. - Share reality (misses, risks, delays) - But anchor it in a clear path forward Example: “We missed two federal deals this quarter—that’s on us. Here’s what we’re changing in our approach and where we’re already seeing traction.” 4. Translate Strategy into “What It Means for Me”: Employees don’t need strategy they need context. - What does this mean for engineering? - For sales? - For customer success? 5. Communicate Change Early and Often GovTech companies often go through: - M&A - Platform transitions - Leadership changes - Communicate before rumors start - Repeat messages across formats (town halls, small groups, written) 6. Use a Clear, Structured Message Every Time: High-performing CEOs follow a consistent communication format: The 5-Part CEO Message Framework - - Where we are (facts) - What’s working - Not working - What we’re doing about it - What we need from you 7. Recognize Teams Publicly and Specifically: In GovTech, wins are often slow and invisible. Highlight: - Customer impact - Delivery milestones - Cross-team collaboration 8. Reinforce a “No Surprises, One Team” Culture: Communication should: - Break down silos - Encourage early escalation CEO tone matters: “Bring problems early” “We solve them together” 9. Adapt the Tone to the Moment - Inspiring (vision, mission) - Direct (misses, accountability) - Calm (during uncertainty or change) - Consistency in tone builds trust. 10. Show You’re Listening (Not Just Talking): Communication is two-way. - Open Q&A (real questions, not filtered) - Small group sessions - Follow-up on employee feedback
-
Charles Egoville liked thisCharles Egoville liked thisSometimes I have to pinch myself that this is what I get to do for a living. This week, Thanh Nguyen and I hosted an Executive Women in Leadership Dinner at Nobu Restaurants in Newport Beach, and I was genuinely blown away by the caliber of women in the room. Hearing the stories behind their careers, leadership journeys, and accomplishments was incredibly inspiring. I’m already looking forward to the next one, more to come.
Experience & Education
-
JM Search
******** *******
-
**** ** *******
********* *******
-
****** *******
** ********* ******* undefined
-
-
********* *******
-
-
View Charles’s full experience
See their title, tenure and more.
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Languages
-
Spanish
-
View Charles’ full profile
-
See who you know in common
-
Get introduced
-
Contact Charles directly
Other similar profiles
Explore more posts
-
IntelePeer
39K followers
🚀 AI is reshaping healthcare—and private equity-backed organizations are leading the charge. In the latest episode of AI Factor's AI Unleashed, Javier Rojas, Founder & Managing Partner at Savant Growth, dives into how AI is driving transformation across PE-backed healthcare organizations. From streamlining operations to reducing costs and delivering measurable outcomes, the impact is real and growing. 💡 Javier shares firsthand insights from Savant Growth’s portfolio, including why DSOs and multi-location providers are at the forefront—and what PE firms and founders should prioritize to unlock transformational value. 🎧 Tune in for data-backed strategies, actionable takeaways, and a compelling look at how AI is becoming a critical lever for healthcare growth. Listen here: https://bit.ly/3IiPu5O #AIUnleashed #HealthcareInnovation #PrivateEquity #AIinHealthcare #AIFactor
6
-
GrowthCap
15K followers
Matt Holt Charts a Scalable Future for Healthcare VC Exits As a private equity leader, Matthew Holt is reshaping the future of healthcare investment by acquiring high-growth AI startups and integrating them into scalable platforms. His most recent effort involves forming a new healthcare AI company aimed at improving hospital revenue operations. It's part of Holt’s growing reputation as the PE exec VCs want to call when IPOs are elusive and Big Tech buyers are on the sidelines. “We identify a problem statement in the industry, and then we put a blueprint together of what would be the company that we would build to best go after that problem,” Holt said in a recent interview. "So what we're really doing is we're taking a page out of the venture studio playbook and applying the same process, but with the advantage of starting with a large-scale private equity fund." New Mountain Capital’s past healthcare bets include building Signify Health, which sold to CVS for $8 billion, and merging Datavant and Ciox Health in a $7 billion deal. “We are very open to partnering with strategics along the way,” Holt told McKinsey in an interview. Holt said value creation doesn’t have to wait for an exit. New Mountain has secured commercial partnerships mid-cycle with larger strategics that help shape product roadmaps and open new pathways for innovation. This collaborative approach reflects Holt’s broader philosophy: New Mountain is helping define the next generation of healthcare infrastructure. By targeting operational inefficiencies and building platform companies around real pain points, Holt’s team creates data-rich assets that incumbents want to align with. VCs have started calling the playbook the "New Mountain special"—a soft landing that offers both a liquidity event and a continued growth path. And unlike traditional PE, Holt’s deals aren’t driven by short-term EBITDA gains. Behind the scenes, Holt has cultivated a wide network of founders and execs, many of whom return for repeat ventures. “There are a number of PE firms that don't really know how to maintain a growth-oriented culture with a founder-led business,” he said. “We make a point to treat everyone well and execute what we say we're going to execute.” With much of the industry reliant on manual processes, he sees room to introduce proven technologies from sectors like financial services and logistics. “We’re really still at the stage of basic building blocks,” Holt said. “And over time, we believe the healthcare industry will follow the same roadmap of other industries.”
-
Aly Madhavji
Blockchain Founders Fund • 30K followers
Institutions don’t fail all at once. They fail when design can’t keep up with change. In Davos this week, I’ll be joining the inaugural gathering of the Institutional Research Network, a new initiative convened by The Digital Economist. The focus is not another set of conversations but the patient work of connecting research, markets, and governance so ideas can take institutional form and hold under real-world pressure. Some initiatives are about visibility. This one is about durability. #Davos2026 #InstitutionalDesign #IRN #TheDigitalEconomist
18
1 Comment -
Lloyd Price
Nelson Advisors • 12K followers
Strategic Analysis of Epic MyChart’s Market Leadership in Patient Engagement The sustained market leading position of Epic MyChart is not attributable solely to superior user experience or functionality, but rather represents a direct, structural consequence of Epic Systems’ foundational dominance in the enterprise Electronic Health Record (EHR) market, particularly among large Integrated Delivery Networks (IDNs). This EHR control provides an insurmountable competitive barrier, securing MyChart’s deployment across vast healthcare ecosystems. This foundational leverage, combined with demonstrable operational Return on Investment (ROI), evidenced by metrics such as reduced appointment no-shows and increased revenue cycle efficiency and accelerated adoption driven by regulatory mandates like the 21st Century Cures Act, creates a powerful competitive moat that effectively marginalises both EHR-tethered rivals and standalone patient portal solutions. https://lnkd.in/epWGEi6e
2
1 Comment -
Pierhead Lighthouse
610 followers
Private equity is changing its playbook. The era of the simple 'roll-up' is ending. Investors are now looking at leadership alignment and operational excellence as the true drivers of valuation for physician groups. Burnout and disruptive behavior aren't just HR issues anymore: they’re financial liabilities. We’ve seen firsthand how targeted executive coaching and mentoring can turn a struggling group into a high-value asset by fixing the team dynamics at the core. Investing in your leaders is the most direct path to increasing your valuation. #PrivateEquity #PhysicianLeadership #ExecutiveCoaching #HealthcareROI
2
-
Silicon Valley Bank
162K followers
The #SVBHealthcare team’s annual report examines how key investment and exit trends are impacting the VC-backed healthcare ecosystem. Check out this year’s report for a: - Ranking of the most active LSHC venture investors - Breakdown of the recent surge in AI healthcare investment - Special section on longevity and healthspan innovation Read the report here: https://lnkd.in/g93SSfwp
77
-
Benori
29K followers
Is private equity quietly becoming the operating system of global healthcare? As healthcare scales under demographic pressure and fiscal constraints, PE is moving beyond capital deployment into platform design, consolidation, and technology-led orchestration. Our report - 𝐓𝐡𝐞 $191 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧, analyzes how this shift is changing investment theses, operating models, and exit pathways across healthcare. 📥 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐫𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/gayxbYRC 👇𝐂𝐨𝐦𝐦𝐞𝐧𝐭 𝐛𝐞𝐥𝐨𝐰: Where do you see the strongest healthcare PE returns ahead? #PrivateEquity #Healthcare #HealthcareInvesting #FutureOfHealthcare #Report #Benori
13
-
Summit Search Consultants
7K followers
In private equity, time is money, and a bad executive hire burns both. The wrong CEO, COO, or CRO can stall value creation faster than you can say “EBITDA.” Our latest guide shows how private equity sponsors and PE portfolio companies can land leaders who actually move the needle. Full article here: https://lnkd.in/gm_z5JZU
7
-
Andy Reid
M3A HealthTech Venture Fund • 8K followers
Why Now Is the Best Time Ever to Invest in Healthcare AI Startups By Andy Reid, Managing Partner, M3A Healthcare Ventures We are entering a once-in-a-generation window for investing in Healthcare AI—one where timing, technology, and major shifts in care are aligning to create outsized opportunities for early-stage venture capital. At M3A Healthcare Ventures, we believe this is the moment to invest boldly. 1. Healthcare Is Ripe for Disruption—And It Has To Be U.S. healthcare costs are projected to hit $7.2 trillion by 2031, yet outcomes lag behind every other developed nation. Workforce shortages, and fractured data systems create inefficiencies that AI is uniquely positioned to solve. • 25% of U.S. healthcare spending is administrative waste. • 90% of hospitals face staffing shortages in key roles. • Doctors spend 2 hours on documentation for every 1 hour with patients. AI isn’t a “nice to have” anymore. It’s becoming a critical tool for cost control, productivity, and quality improvement. 2. We’ve Entered the Platform Shift Era Apple Intelligence, OpenAI, and other foundation models have catalyzed a new generation of startups. In healthcare, this means real-time ambient documentation, predictive care, smart inventory management, and even AI-generated clinical trial design—all happening today. This is akin to investing in SaaS in 2006 or mobile apps in 2011. Except this time, the TAM is $4 trillion larger. 3. Buyers Are Ready—and They’re Buying Just five years ago, hospitals were wary of AI. Today, they’re budgeting for it. Health systems, ASCs, pharma, and insurers are deploying capital to integrate AI that: • Shortens revenue cycles • Boosts clinician efficiency • Reduces preventable readmissions • Enhances training and education with immersive tools In short: the demand isn’t theoretical—it’s contractually real. 4. Healthcare AI Has Multiple High-Value Exit Paths M&A activity is accelerating, and healthcare AI companies are being acquired by: • Strategics like Stryker (e.g., $130M for care.ai) • PE-backed rollups seeking operational efficiency • Big Tech, which is aggressively moving into healthcare These aren’t just tech exits. They’re life sciences, SaaS, and data infrastructure exits rolled into one—often with 3–5x higher revenue multiples. 5. We Have the Talent, Data, and Infrastructure The convergence of: • Open health data regulations (ONC Cures Act) • AI-native medical founders trained in both tech and care delivery • Decreasing costs and better modeling We finally have a clear runway to build and scale. The Next MedTech Unicorns Will Be AI-First The next wave will be built on data, AI, and automation. Investors who move now will back the next Teladoc, Intuitive, or Epic—except leaner, faster, and born in the AI-native era. #HealthcareAI #HealthTech #VentureCapital #DigitalHealth #AIinHealthcare #MedTech #ArtificialIntelligence #StartupInvestment #HealthTechStartups #VCFunding #AIStartup
46
2 Comments -
Vivian Guo
ICONIQ • 2K followers
For the last decade, tech companies optimized for scale: repeatable hiring plans, functional specialization, predictable org charts. I think the next decade will be defined by something harder to achieve: leverage. The defining trait of AI-first companies won’t necessarily be how much AI they deploy. It will be how willing they are to revisit long-held assumptions about what work exists, who should do it, and how organizations should be structured in the first place. Very excited to finally share the thought piece we at ICONIQ have been working on. Thank you to the many contributors Anu Bharadwaj Dennis Lyandres Diane K. Adams Kipp Bodnar Matt Eccleston Michael Curtis Michelle Morris Jesse Collins Patrick Forquer Rob Bernshteyn who shared their perspectives. This space is evolving faster than any single perspective can capture. If you’re experimenting with new workforce models, seeing something different in your organization, or simply disagree with parts of this thesis, I’d love to hear from you! https://lnkd.in/g66NxYVK
63
2 Comments -
WittKieffer
46K followers
"Interim CFOs bring discipline and clarity to investor-backed healthcare companies. Beyond stabilizing reporting, they act as strategic partners to founder CEOs..." - Sandeep P., a private equity-backed interim CFO First institutional capital investments in healthcare face unique challenges where financial gaps can fracture value creation plans. We identify five critical risk areas in these critical transitions: · Financial reporting opacity · Infrastructure and scalability constraints · Margin and pricing erosion · Exit readiness deficits · Compliance landmines Learn more about how interim and on-demand solutions transform financial challenges into value creation opportunities: #InvestorBackedHealthcare #FinanceLeadership #InterimSolutions
5
-
Sara Choi
Wing Venture Capital • 13K followers
Healthcare isn’t evolving gradually anymore. It’s being forced forward. That was the consistent message from the 300+ CEOs and healthcare leaders we had the privilege of hosting at our Wing at JPM Summit. Following the event, my teammate, Ansuman Satpathy, and I put together a 2026 predictions survey to capture how leaders across pharma, providers, payors, regulators, technologists, and investors see the next phase of healthcare unfolding. 👉 The therapeutic modality predicted to have the most impact in the next 5 years? CELL AND GENE THERAPIES, voted #1 by a whopping 44% of leaders (small molecules only got 12% of the votes). Take note, early-stage investors! 👉 Drug development is accelerating, with leaders predicting a 52% INCREASE in FDA approvals over the next decade 👉 Cost pressure is intensifying, with a median 15% expected reduction in administrative costs from AI within three years What excited me most wasn’t just the numbers. It's the shared belief that this moment will unlock truly personalized medicine, better interventions earlier in the care journey, and real progress on access that goes far beyond prescriptions. This is no longer an experimentation phase. It’s an acceleration moment for healthcare and biotech. See how healthcare leaders are thinking about 2026 in the full survey: https://lnkd.in/gt3YREWk @Wing Venture Capital
105
5 Comments -
Raheel Khan
Alvarez & Marsal • 4K followers
MedTech and HealthIT drove record deal volume last year thanks to larger-than-average number of high-value transactions. All signs point to an active year for the sector as portfolios mature and exit pipelines build. Read more: https://okt.to/Ol62IX #healthcare #medtech #HealthIT #MergersAndAcquisitons
44
1 Comment -
Nguyen Tung Anh
TPG • 585 followers
Refining Healthcare PE: When "Operational Certainty" Drives Alpha After several recent PMI reviews, one thing is clear: generating returns via information asymmetry or multiple expansion is over. As an Operating Partner, my focus is now on the "Post-1,000 Days"—shifting from deal selection to systemic re-engineering. 1. Scalability vs. Unit Economics "Buy-and-Build" now requires an efficiency-first logic. Without stress-tested unit economics, rapid scaling is just an exponential stacking of risks. Our priority is exporting a standardized "management language"—from procurement to Clinical Pathways. Scale only yields a premium when every "nerve ending" operates efficiently. 2. Digital Governance: Reclaiming Productivity I’m increasingly scrutinizing the "frictional costs" of digitalization. A true value creation model must unlock core productivity. Does AI genuinely reduce non-clinical hours? Can data-hubs drive synergy under complex regulations? If digital investment doesn’t structurally optimize EBITDA margins, it’s just a sunk cost. 3. The "Translator" Role A core moat for an Operating Partner is cross-contextual translation: converting financial KPIs into professional milestones that physicians and R&D teams rally behind. Helping investors see clinical outcomes as the ultimate moat is the prerequisite for any strategic execution. 4. The Quality Premium The market is re-rating enterprises that uphold clinical rigor. Embedding quality metrics directly into corporate governance is peak commercial rationality: superior clinical outcomes mean lower acquisition costs, stronger bargaining power, and natural brand barriers. Closing: In a volatile cycle, certainty is hidden within the most tedious operational details. That’s where real value is created. #HealthcareInvestment #PrivateEquity #OperatingPartner #ValueCreation #PMI #LifeSciences #MarketInsights
3
-
hlthworks
120 followers
In 2026, HLTHWorks has collaborated with over 25 healthcare board of directors - from start ups, mid-size, to $1-$10 billion dollar entities, and a select few in the pre-exit phase. Here is a bit of our work with health plan boards. #healthplan #healthcare #boardofdirectors https://lnkd.in/gSTNiYCs
3
-
Mike Mortimer
GHO Capital Partners LLP • 3K followers
Over the weekend, alongside Sam Ulin of ClearView Healthcare Partners, I discussed how the rise of integrated direct-to-consumer (DTC) models marks a foundational shift for pharma, streamlining access, empowering patients, and redefining how treatments are promoted, prescribed, and delivered. What started in obesity care is now expanding across therapeutic areas. The momentum is clear that patient-first models aren't just better for patients, they enable faster access and greater innovation. Read the piece in BioCentury Inc.: https://lnkd.in/ejqJbhJh #DTC #Innovation #Obesity #Healthcare #PatientFirst
78
2 Comments -
Tucker Twitmyer
JM Search • 8K followers
@Alissa Moddy recently wrote about the thinning bench of serial PE CEOs and c-suite execs. @Scott Wieler has followed up with an exploration of go-to-market professionals - CROs, CCOs, VPs of Sales - and the transition to sponsor-backed cultures. Are you thinking about bringing a sales leader from corporate? Full article here: https://lnkd.in/e3S6aU9G
10
1 Comment
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content